Speak with Max on the Air
Call (512) 643-LIVE (5483) Sundays 3pm – 4pm
Listen Live to Max on Radio
Sundays, 3:00-4:00 pm
"I read Max, he makes me a little angry sometimes, and I wish I could call him fake news, but I can't"
"For me, when it's Miller Time, that means it's time to read Max Miller"
Press the play icon to listen to Max's latest broadcast
Max gets to midweek and jumps right into government debt, the deficit, and trade, which at one point Max thought the GOP was really, really worried about.
Now apparently not so much. Max is often criticized for going after the GOP too much, but now he reminds the Democrats how they seem have lost with their roots as is shown in recent polling. Finally max wonders again about the so-called special relationship between the UK and the US.
Tell Max What You Think!
Max gets to his next show accompanied by the Max Miller Dog, and Dan his Long Suffering Producer, and jumps right into the latest Democratic Debate, which he calls a nightmare version of speed dating.
Next gets into the Supreme Court’s decision not to get involved decision regarding Gerrymandering, and leaves it up to the poor voters in the states to sort out. Tariffs, the 737 Max, and Trump round out the show.
Max and Ginger get back to their regular routine with their weekly roundup show, which covers such diverse topics as;
the size of the Russian economy, Hillary Clinton was a useless candidate (according to Max anyway), tariffs yet again, and then finally for some reason, Ginger wanted to talk about the Electoral College. Exciting stuff!
Max gets to the last show of the week, without Mike and Ginger, but he does have Dan his Long Suffering Producer in the house, making all the buttons work.
Before Max gets to the hot topic of the price of insulin and other prescription drug prices in the US, he digs into Google for not protecting business interests of their advertisers. Next Max revisits an old gripe, and that is why do we care so much about Russia, when it is essentially broke? Eventually Max gets to the topic of Eli Lilly, and the Health and Human Services secretary Alex Azar.